It is with great pleasure that we invite you to the 2021 Australasian Melanoma Conference (AMC2021) to be held in Sydney, Australia from 19-20 November 2021. The conference, hosted by Melanoma Institute Australia, will bring together clinicians and researchers from across Australia, New Zealand and beyond to discuss exciting advancements in melanoma from ground-breaking discoveries to practice-changing clinical management.
Held at the Sheraton Grand Sydney Hyde Park, the conference will feature keynote addresses from national and international experts outlining the current research and clinical landscape of melanoma. Delegates will have the opportunity to focus on specific areas of interest including diagnosis, survivorship, and the treatment of early stage and advanced disease, with particular attention to new targeted and immune therapies. In addition, we will have dedicated sessions for General Practitioners, ensuring our latest understanding of melanoma is translated into the clinic setting to ultimately improve patient care.
We are proud to bring a patient-centric focus to AMC2021, and we are reminded why we dedicate our careers to benefit people with melanoma. Our theme is “Promising Futures”, celebrating how—thanks to advancements in research in the past decade—the future for melanoma patients is now promising. It also reflects on the idea that we have promising futures thanks to the many great minds working collaboratively towards our common goal of zero deaths from melanoma.
|Early Bird Open||Now|
|Call for Abstracts Open||Now|
|Deadline Call for Abstracts||17 July 2021|
|Early Bird Close||19 September 2021|
|Notifications of Abstracts||23 August 2021|
|Presenters Final Registration Date||19 September 2021|
|AMC 2021||19 – 20 November 2021|